Chi Sheng Pharma & Biotech Co., Ltd (TPEX:4111)

TPEX:4111 Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	321.32	336.19	381.05	456.25	252.27	335.8
Cash & Short-Term Investments	321.32	336.19	381.05	456.25	252.27	335.8
Cash Growth	-15.37%	-11.77%	-16.48%	80.86%	-24.88%	22.02%
Accounts Receivable	333.95	326.5	309.71	282.64	281.4	247.78
Other Receivables	21.26	18.58	19.94	0.66	0.81	1
Receivables	355.2	345.07	329.65	283.3	282.2	248.78
Inventory	105.42	96.85	89.17	99.03	90.25	85.39
Prepaid Expenses	5.5	6.49	4.11	2.23	9.92	13.62
Other Current Assets	0.05	0.02	0.02	16.82	16.83	0.01
Total Current Assets	787.49	784.62	804	857.64	651.47	683.6
Property, Plant & Equipment	747.14	756.98	720.35	785.33	899.42	717.45
Long-Term Investments	1.8	1.81	1.84	3.48	3.97	3.43
Other Intangible Assets	1.62	1.63	1.46	1.04	0.9	0.97
Long-Term Deferred Tax Assets	3.77	11.23	35.54	54.2	6.1	7.98
Other Long-Term Assets	240.13	193.37	202.92	98.84	97.92	73.3
Total Assets	1,782	1,750	1,766	1,801	1,660	1,487
Accounts Payable	254.39	240.28	226.33	237.03	205.74	188.81
Short-Term Debt	10	10	120	120	130	-
Current Portion of Leases	12.1	9.53	2.12	6.11	6.72	5.49
Current Income Taxes Payable	6.5	1	1.2	18.7	14.01	9.98
Current Unearned Revenue	0.16	0.14	1.17	4.77	7.79	12.01
Other Current Liabilities	93.31	111.85	100.63	95.29	82.63	76.23
Total Current Liabilities	376.45	372.8	451.46	481.89	446.88	292.53
Long-Term Leases	5.07	7.09	0.78	2.28	7.28	7.04
Long-Term Deferred Tax Liabilities	77.05	79.94	76.52	77.85	76.52	76.52
Other Long-Term Liabilities	6.19	6.35	7.05	7.29	9.75	9.87
Total Liabilities	468.65	475.08	547.04	578.38	559.04	410.93
Common Stock	569.83	569.83	569.83	569.83	569.83	569.83
Additional Paid-In Capital	48.85	48.85	48.85	48.85	48.85	48.85
Retained Earnings	697.46	658.71	603.19	604.63	506.39	481.54
Comprehensive Income & Other	-2.84	-2.84	-2.8	-1.16	-24.33	-24.43
Shareholders' Equity	1,313	1,275	1,219	1,222	1,101	1,076
Total Liabilities & Equity	1,782	1,750	1,766	1,801	1,660	1,487
Total Debt	27.17	26.62	122.9	128.38	144	12.53
Net Cash (Debt)	294.16	309.57	258.15	327.87	108.27	323.27
Net Cash Growth	18.76%	19.92%	-21.26%	202.84%	-66.51%	24.34%
Net Cash Per Share	5.13	5.40	4.51	5.72	1.89	5.65
Filing Date Shares Outstanding	56.98	56.98	56.98	56.98	56.98	56.98
Total Common Shares Outstanding	56.98	56.98	56.98	56.98	56.98	56.98
Working Capital	411.04	411.82	352.54	375.74	204.59	391.06
Book Value Per Share	23.05	22.37	21.39	21.45	19.32	18.88
Tangible Book Value	1,312	1,273	1,218	1,221	1,100	1,075
Tangible Book Value Per Share	23.02	22.34	21.37	21.43	19.30	18.86
Land	371.9	371.9	371.9	478.28	478.28	242.77
Buildings	649.48	662.04	636.77	538.78	703.06	708.18
Machinery	585.34	585.74	549.8	529.11	569.08	556.68
Construction In Progress	38.2	36.28	30.51	82.48	2.96	-
Leasehold Improvements	3.04	2.44	2.29	3.41	3.41	3.41

Source: S&P Global Market Intelligence. Standard template. Financial Sources.